Tags

Type your tag names separated by a space and hit enter

Orally disintegrating rimegepant increased freedom from pain and from most bothersome symptom at 2 h in acute migraine.
Ann Intern Med. 2019 11 19; 171(10):JC58.AIM

Authors

No affiliation info available

Pub Type(s)

Journal Article
Comment

Language

eng

PubMed ID

31739341

Citation

McCarthy, Lucas. "Orally Disintegrating Rimegepant Increased Freedom From Pain and From Most Bothersome Symptom at 2 H in Acute Migraine." Annals of Internal Medicine, vol. 171, no. 10, 2019, pp. JC58.
McCarthy L. Orally disintegrating rimegepant increased freedom from pain and from most bothersome symptom at 2 h in acute migraine. Ann Intern Med. 2019;171(10):JC58.
McCarthy, L. (2019). Orally disintegrating rimegepant increased freedom from pain and from most bothersome symptom at 2 h in acute migraine. Annals of Internal Medicine, 171(10), JC58. https://doi.org/10.7326/ACPJ201911190-058
McCarthy L. Orally Disintegrating Rimegepant Increased Freedom From Pain and From Most Bothersome Symptom at 2 H in Acute Migraine. Ann Intern Med. 2019 11 19;171(10):JC58. PubMed PMID: 31739341.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Orally disintegrating rimegepant increased freedom from pain and from most bothersome symptom at 2 h in acute migraine. A1 - McCarthy,Lucas, PY - 2019/11/19/entrez PY - 2019/11/19/pubmed PY - 2020/4/2/medline SP - JC58 EP - JC58 JF - Annals of internal medicine JO - Ann. Intern. Med. VL - 171 IS - 10 SN - 1539-3704 UR - https://www.unboundmedicine.com/medline/citation/31739341/Orally_disintegrating_rimegepant_increased_freedom_from_pain_and_from_most_bothersome_symptom_at_2_h_in_acute_migraine L2 - https://www.annals.org/aim/fullarticle/doi/10.7326/ACPJ201911190-058 DB - PRIME DP - Unbound Medicine ER -